363 related articles for article (PubMed ID: 19832632)
1. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
2. Influence of MCC II fraction and storage conditions on pellet properties.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
[TBL] [Abstract][Full Text] [Related]
3. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
Liew CV; Gu L; Soh JL; Heng PW
Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
[TBL] [Abstract][Full Text] [Related]
4. Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.
Sarkar S; Heng PW; Liew CV
Pharm Dev Technol; 2013 Feb; 18(1):61-72. PubMed ID: 21981607
[TBL] [Abstract][Full Text] [Related]
5. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
6. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
7. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
[TBL] [Abstract][Full Text] [Related]
8. Use of extrusion aids for successful production of Kollidon
Loka NC; Saripella KK; Pinto CA; Neau SH
Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
[TBL] [Abstract][Full Text] [Related]
9. Influence of starting material particle size on pellet surface roughness.
Sarkar S; Ang BH; Liew CV
AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
[TBL] [Abstract][Full Text] [Related]
10. Approaches to developing fast release pellets via wet extrusion-spheronization.
Xia Y; Shi CY; Fang JG; Wang WQ
Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
[TBL] [Abstract][Full Text] [Related]
11. The behavior of different carrageenans in pelletization by extrusion/spheronization.
Thommes M; Kleinebudde P
Pharm Dev Technol; 2008; 13(1):27-35. PubMed ID: 18300097
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of microcrystalline cellulose II (MCCII) as an alternative extrusion-spheronization aid.
Rojas J; Kumar V
Pharmazie; 2012 Jul; 67(7):595-7. PubMed ID: 22888514
[TBL] [Abstract][Full Text] [Related]
13. Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid.
Jain SP; Mehta DC; Shah SP; Singh PP; Amin PD
AAPS PharmSciTech; 2010 Jun; 11(2):917-23. PubMed ID: 20499219
[TBL] [Abstract][Full Text] [Related]
14. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of pellets using Avicel CL611 as spheronization aid.
Puah SY; Yap HN; Chaw CS
Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
[TBL] [Abstract][Full Text] [Related]
16. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853
[TBL] [Abstract][Full Text] [Related]
17. Use of the direct compression aid Ludiflash(®) for the preparation of pellets via wet extrusion/spheronization.
Roblegg E; Schrank S; Griesbacher M; Radl S; Zimmer A; Khinast J
Drug Dev Ind Pharm; 2011 Oct; 37(10):1231-43. PubMed ID: 21438702
[TBL] [Abstract][Full Text] [Related]
18. Influence of the surface tension of wet massing liquid on the functionality of microcrystalline cellulose as pelletization aid.
Elsergany RN; Lenhart V; Kleinebudde P
Eur J Pharm Biopharm; 2020 Aug; 153():285-296. PubMed ID: 32599270
[TBL] [Abstract][Full Text] [Related]
19. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures.
Kleinebudde P; Schröder M; Schultz P; Müller BW; Waaler T; Nymo L
Pharm Dev Technol; 1999 Aug; 4(3):397-404. PubMed ID: 10434285
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
Ibrahim MA
Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]